152 related articles for article (PubMed ID: 32218847)
1. BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
Wang X; Xu Y; Xu K; Chen Y; Xiao X; Guan X
Oncol Lett; 2020 Apr; 19(4):2916-2924. PubMed ID: 32218847
[TBL] [Abstract][Full Text] [Related]
2. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract][Full Text] [Related]
3. Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype.
Angius A; Pira G; Cossu-Rocca P; Sotgiu G; Saderi L; Muroni MR; Virdis P; Piras D; Vincenzo R; Carru C; Coradduzza D; Uras MG; Cottu P; Fancellu A; Orrù S; Uva P; De Miglio MR
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3951-3963. PubMed ID: 36030436
[TBL] [Abstract][Full Text] [Related]
4. ZMIZ2 promotes the development of triple-receptor negative breast cancer.
Zou X; Liu Y; Di J; Wei W; Watanabe N; Li J; Li X
Cancer Cell Int; 2022 Jan; 22(1):52. PubMed ID: 35101047
[TBL] [Abstract][Full Text] [Related]
5. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
[TBL] [Abstract][Full Text] [Related]
7. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.
Chen B; Wei W; Huang X; Xie X; Kong Y; Dai D; Yang L; Wang J; Tang H; Xie X
Theranostics; 2018; 8(14):4003-4015. PubMed ID: 30083277
[TBL] [Abstract][Full Text] [Related]
8. BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.
Khaled WT; Choon Lee S; Stingl J; Chen X; Raza Ali H; Rueda OM; Hadi F; Wang J; Yu Y; Chin SF; Stratton M; Futreal A; Jenkins NA; Aparicio S; Copeland NG; Watson CJ; Caldas C; Liu P
Nat Commun; 2015 Jan; 6():5987. PubMed ID: 25574598
[TBL] [Abstract][Full Text] [Related]
9. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
Riaz N; Idress R; Habib S; Lalani EN
Front Oncol; 2020; 10():1083. PubMed ID: 32850312
[No Abstract] [Full Text] [Related]
10. The transcriptional repressor BCL11A promotes breast cancer metastasis.
Seachrist DD; Hannigan MM; Ingles NN; Webb BM; Weber-Bonk KL; Yu P; Bebek G; Singh S; Sizemore ST; Varadan V; Licatalosi DD; Keri RA
J Biol Chem; 2020 Aug; 295(33):11707-11719. PubMed ID: 32576660
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer.
Kucukzeybek BB; Bayoglu IV; Kucukzeybek Y; Yıldız Y; Oflazoglu U; Atahan MK; Taskaynatan H; Alacacioglu A; Yigit S; Tarhan MO
Pol J Pathol; 2018; 69(2):157-168. PubMed ID: 30351863
[TBL] [Abstract][Full Text] [Related]
12. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
Abd-Elazeem MA; Abd-Elazeem MA
Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
14. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
15. AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells.
Li S; Lee W; Heo W; Son HY; Her Y; Kim JI; Moon HG
J Breast Cancer; 2023 Feb; 26(1):60-76. PubMed ID: 36762781
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
Choi JE; Kang SH; Lee SJ; Bae YK
Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.
Liu YX; Zhang KJ; Tang LL
Oncol Lett; 2018 Jun; 15(6):10008-10016. PubMed ID: 29844843
[TBL] [Abstract][Full Text] [Related]
19. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
20. An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer.
Yang F; Shen Y; Zhang W; Jin J; Huang D; Fang H; Ji W; Shi Y; Tang L; Chen W; Zhou G; Guan X
Cell Death Differ; 2018 Dec; 25(12):2209-2220. PubMed ID: 29844570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
